Jasper Therapeutics, Inc.
JSPR
$0.46
$0.00-0.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.10M | -18.74M | -26.72M | -21.24M | -24.32M |
| Total Depreciation and Amortization | 290.00K | 229.00K | 258.00K | 279.00K | 245.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.33M | 1.70M | 2.13M | 2.00M | 2.10M |
| Change in Net Operating Assets | -9.73M | -187.00K | 8.88M | -3.88M | 842.00K |
| Cash from Operations | -21.87M | -17.00M | -15.45M | -22.84M | -21.13M |
| Capital Expenditure | 0.00 | 0.00 | -7.00K | -- | -96.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 8.00K | 4.00K | 20.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 1.00K | 4.00K | -76.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 28.39M | 6.16M | -- | 345.00K |
| Repurchase of Common Stock | -340.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -340.00K | 28.39M | 6.16M | -- | 345.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.21M | 11.39M | -9.29M | -22.84M | -20.87M |